- Home
- PRTA vs BWMX Comparison
PRTA vs BWMX Comparison
Compare PRTA & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- BWMX
- Stock Information
- Founded
- PRTA 2012
- BWMX 1995
- Country
- PRTA Ireland
- BWMX Mexico
- Employees
- PRTA N/A
- BWMX N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- BWMX Catalog/Specialty Distribution
- Sector
- PRTA Health Care
- BWMX Consumer Discretionary
- Exchange
- PRTA Nasdaq
- BWMX Nasdaq
- Market Cap
- PRTA 472.1M
- BWMX 495.6M
- IPO Year
- PRTA N/A
- BWMX N/A
- Fundamental
- Price
- PRTA $8.20
- BWMX $13.29
- Analyst Decision
- PRTA Buy
- BWMX Strong Buy
- Analyst Count
- PRTA 10
- BWMX 1
- Target Price
- PRTA $14.86
- BWMX $22.50
- AVG Volume (30 Days)
- PRTA 1.2M
- BWMX 55.5K
- Earning Date
- PRTA 08-04-2025
- BWMX 10-23-2025
- Dividend Yield
- PRTA N/A
- BWMX 10.75%
- EPS Growth
- PRTA N/A
- BWMX N/A
- EPS
- PRTA N/A
- BWMX 0.84
- Revenue
- PRTA $10,341,000.00
- BWMX $751,432,052.00
- Revenue This Year
- PRTA N/A
- BWMX $6.54
- Revenue Next Year
- PRTA $389.77
- BWMX $6.09
- P/E Ratio
- PRTA N/A
- BWMX $15.88
- Revenue Growth
- PRTA N/A
- BWMX 4.83
- 52 Week Low
- PRTA $4.32
- BWMX $7.00
- 52 Week High
- PRTA $22.83
- BWMX $14.46
- Technical
- Relative Strength Index (RSI)
- PRTA 58.73
- BWMX 62.09
- Support Level
- PRTA $8.05
- BWMX $13.06
- Resistance Level
- PRTA $8.73
- BWMX $13.50
- Average True Range (ATR)
- PRTA 0.38
- BWMX 0.45
- MACD
- PRTA -0.05
- BWMX -0.13
- Stochastic Oscillator
- PRTA 47.62
- BWMX 66.64
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.